Retinitis Pigmentosa Clinical Trials in Miami, FL

View the best 10 retinitis pigmentosa medical studies in Miami, Florida. Access promising new therapies by applying to a Miami-based Retinitis Pigmentosa clinical trial.

Trials in Miami, Florida

Here are the top 4 medical studies for retinitis pigmentosa in Miami, Florida

Michael Bask Gill, B Sc

Last Reviewed: December 7th, 2024

N-acetylcysteine

Antioxidant

Recruiting1 awardPhase 3

This trial is testing if N-acetylcysteine (NAC) can help slow down vision loss in people with Retinitis Pigmentosa (RP). RP is a genetic condition that causes gradual vision loss. NAC reduces damage caused by too much oxygen around eye cells, potentially protecting vision. N-acetylcysteine (NAC) has been shown to reduce oxidative damage and increase cone function/survival in studies related to RP.

OCU400

Gene Therapy

Recruiting2 awardsPhase 3

"This trial is testing a new drug called OCU400 in 150 patients with retinitis pigmentosa (RP) caused by RHO mutations or other RP-associated mutations. The study will evaluate how

Electro-acupuncture +1 More

Behavioural Intervention

Recruiting0 awards6 criteria

This trial is testing a treatment called transcorneal electrical stimulation for people with retinitis pigmentosa, a condition that leads to gradual vision loss. The treatment uses small electrical currents applied to the eye to improve blood flow and stimulate retinal cells, which may help slow down vision loss. Transcorneal electrical stimulation has shown several improvements in visual function in previous studies and is currently offered by several companies.

Arm 1 +2 More

Stem Cell Therapy

Recruiting1 award8 criteria

This trial will use stem cells from patients' own bone marrow to treat severe vision loss caused by retinal or optic nerve damage. The stem cells will be injected into the eye to help repair the damaged tissues. SCOTS is the largest ophthalmology stem cell study registered at the National Institutes of Health, using autologous bone marrow-derived stem cells for retinal and optic nerve diseases.

Popular Filters

Trials With No Placebo

Gene Therapy

Gene Therapy for Retinitis Pigmentosa

Recruiting2 awardsPhase 3

Miami, Florida

"This trial is testing a new drug called OCU400 in 150 patients with retinitis pigmentosa (RP) caused by RHO mutations or other RP-associated mutations. The study will evaluate how

Gene Therapy

AGTC-501 for Retinitis Pigmentosa

Recruiting1 awardPhase 2

Miami, Florida

This trial will test the safety of AGTC-501 in people with X-linked retinitis pigmentosa who have already received a gene therapy treatment for the condition.

Gene Therapy

Gene Therapy with SPVN06 for Cone-Rod Dystrophy

Recruiting1 awardPhase 1 & 2

Miami, Florida

This trial is testing a new treatment for patients with advanced vision problems caused by specific genetic mutations. The study aims to determine the appropriate dose and evaluate its effectiveness.

Virus Therapy

AGTC-501 for Retinitis Pigmentosa

Recruiting1 awardPhase 2 & 3

Miami, Florida

This trial will test two different doses of a gene therapy called AGTC-501 to see how safe and effective it is in treating a certain type of eye disease in men.

Gene Therapy

Gene Therapy for Leber Congenital Amaurosis

Recruiting1 awardPhase 1 & 2

Miami, Florida

This trial is testing a new gene therapy for people with a specific genetic mutation that causes Leber Congenital Amaurosis, a severe form of vision loss.

Gene Therapy

BIIB111 for Choroideremia & BIIB112 for X-Linked Retinitis Pigmentosa

Recruiting2 awardsPhase 3

Miami, Florida

This trial will compare the long-term safety and efficacy of a sub-retinal injection of BIIB111 in participants with Choroideremia (CHM) who have been previously treated with BIIB111, with untreated control participants who have exited the STAR (NCT03496012) study. The trial will also compare BIIB112 in participants with X-linked retinitis pigmentosa (XLRP) who have been previously treated with BIIB112.

View more retinitis-pigmentosa clinical trials miami

See more medical studies focusing on retinitis-pigmentosa miami

Frequently Asked Questions

Do I need insurance to participate in a trial?

Almost all clinical trials will cover the cost of the 'trial drug' — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).

Is there any support for travel costs?

Many of the teams running clinical trials will cover the cost of transportation to-and-from their care center.

Will I know what medication I am taking?

This depends on the specific study. If you're worried about receiving a placebo, you can actively filter out these trials using our search.

How long do clinical trials last?

Some trials will only require a single visit, while others will continue until your disease returns. It's fairly common for a trial to last somewhere between 1 and 6 months.

Do you verify all the trials on your website?

All of the trials listed on Power have been formally registered with the US Food and Drug Administration. Beyond this, some trials on Power have been formally 'verified' if the team behind the trial has completed an additional level of verification with our team.

How quickly will I hear back from a clinical trial?

Sadly, this response time can take anywhere from 6 hours to 2 weeks. We're working hard to speed up how quickly you hear back — in general, verified trials respond to patients within a few days.